Here are what the editors at HealthDay consider to be the most important developments in Cosmetic Surgery for January 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Report IDs Areas Lacking Good Practice in Health Tech Assessment
FRIDAY, Jan. 25, 2019 (HealthDay News) — In a report published in the January issue of Value in Health, an ISPOR–The Professional Society for Health Economics and Outcomes Research working group indicates the lack of good practices in three areas of health technology assessment (HTA).
Mandibular Contour Surgery Training System Beneficial
FRIDAY, Jan. 18, 2019 (HealthDay News) — An intraoral mandibular contour surgery (MCS) training system is effective for improving clinical surgery time and accuracy, according to a study published online Jan. 17 in JAMA Facial Plastic Surgery.
FDA Down to 5 Weeks of Funding to Review New Drug Applications
THURSDAY, Jan. 17, 2019 (HealthDay News) — Due to the federal government shutdown, the U.S. Food and Drug Administration has only about five weeks of funding left to review new drug applications, according to Commissioner Scott Gottlieb, M.D.
CNN News Article
Adoption of Advanced Health IT Capabilities Inconsistent
WEDNESDAY, Jan. 16, 2019 (HealthDay News) — Adoption of advanced health information technology (HIT) capabilities is inconsistent across health care systems, with electronic health record (EHR) standardization being the strongest predictor of advanced capabilities, according to a study published in the January issue of the American Journal of Managed Care.
American College of Physicians Releases 7th Edition of Ethics Manual
TUESDAY, Jan. 15, 2019 (HealthDay News) — Ethical principles are discussed in an updated Ethics Manual, issued by the American College of Physicians (ACP) and published as a supplement to the Jan. 15 issue of the Annals of Internal Medicine.
American College of Physicians Ethics Manual
Editorial (subscription or payment may be required)
Prices Still Explain High U.S. Health Care Spending
FRIDAY, Jan. 11, 2019 (HealthDay News) — The difference in health spending between the United States and other countries is still explained by health care prices, according to a study published in the January issue of Health Affairs.
Private Equity Acquisition of Physician Practices Discussed
THURSDAY, Jan. 10, 2019 (HealthDay News) — The phenomenon of private equity acquisition of physician practices is discussed in an Ideas and Opinions piece published online Jan. 8 in the Annals of Internal Medicine.
Many Female Health Care Workers Live in Poverty
WEDNESDAY, Jan. 9, 2019 (HealthDay News) — Many U.S. female health care workers, particularly women of color, live in poverty and lack health insurance, according to a study published online Dec. 20 in the American Journal of Public Health.
Increase in Brand-Name Drug Cost Mainly Due to Existing Drugs
WEDNESDAY, Jan. 9, 2019 (HealthDay News) — The costs of oral and injectable brand-name drugs increased from 2008 to 2016, with most of the increase due to existing drugs, while new drugs accounted for cost increases in specialty and generic drugs, according to a study published in the January issue of Health Affairs.
Medical Marketing Has Increased in Past 20 Years
TUESDAY, Jan. 8, 2019 (HealthDay News) — From 1997 through 2016, there was an increase in medical marketing, especially direct-to-consumer (DTC) advertising, according to research published in the Jan. 1/8 issue of the Journal of the American Medical Association.
ACA Coverage Gains Could Erode Without Individual Mandate
TUESDAY, Jan. 8, 2019 (HealthDay News) — Eliminating the Affordable Care Act’s individual mandate penalty is unlikely to destabilize the individual market in California but could roll back coverage gains, according to a study published in the January issue of Health Affairs.
Meta-Analysis: Botulinum A Tops Placebo for Chronic Migraine
MONDAY, Jan. 7, 2019 (HealthDay News) — For chronic migraine, botulinum type A injections are superior to placebo after three months of therapy, according to a meta-analysis published in the January issue of Plastic and Reconstructive Surgery.
Copyright © 2019 ScoutNews, LLC. All rights reserved.
